Prognostic impact of low allelic ratio FLT3- ITD and NPM1 mutation in acute myeloid leukemia

Clicks: 637
ID: 110896
2018
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #2 of 7 articles by views in blood advances

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
In the opinion of the European LeukemiaNet (ELN), nucleophosmin member 1 gene mutation (NPM1 mut)-positive acute myeloid leukemia (AML) with an fms-like kinase 3-internal tandem duplication (FLT3-ITD) allele ratio (AR) <0.5 (low AR) has a favorable prognosis, and allogeneic hematopo …
Reference Key
m2018bloodprognostic Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Sakaguchi M;Yamaguchi H;Najima Y;Usuki K;Ueki T;Oh I;Mori S;Kawata E;Uoshima N;Kobayashi Y;Kako S;Tajika K;Gomi S;Shono K;Kayamori K;Hagihara M;Kanda J;Uchiyama H;Kuroda J;Uchida N;Kubota Y;Kimura S;Kurosawa S;Nakajima N;Marumo A;Omori I;Fujiwara Y;Yui S;Wakita S;Arai K;Kitano T;Kakihana K;Kanda Y;Ohashi K;Fukuda T;Inokuchi K;;
Journal blood advances
Year 2018
DOI
DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.